Back to search
Inherited Metabolic Disorders (IMD)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Inherited Metabolic Disorders (IMD) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Inherited Metabolic Disorders (IMD) trials you may qualify forThis is a data collection study that will examine the general diagnostic and treatment data associated with the reduced-intensity chemotherapy-based regimen pai…
The objective of this study is to evaluate the efficacy of using a reduced-intensity condition (RIC) regimen with umbilical cord blood transplant (UCBT), double…
This single-institution, phase II study is designed to test the ability to achieve donor hematopoietic engraftment while maintaining low rates of transplant-rel…
This study is designed to assess the safety and efficacy of using MGTA-456 in patients with Inherited Metabolic Disorders (IMD) undergoing stem cell transplanta…
A follow-up study to evaluate the safety and clinical outcomes of patients with inherited metabolic disorders (IMD) who have undergone hematopoietic stem cell t…